Complex Interaction Between Visceral Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease

Vincent Wai-Sun Wong^{1

2}

Affiliations

¹ Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
² State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

Editorial

Vincent Wai-Sun Wong. J Clin Exp Hepatol. 2025 Jan-Feb.

. 2025 Jan-Feb;15(1):102426.

doi: 10.1016/j.jceh.2024.102426. Epub 2024 Oct 15.

Vincent Wai-Sun Wong^{1

2}

¹ Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
² State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

No abstract available

References

1. Powell E.E., Wong V.W., Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212–2224. - PubMed
1. Lin H., Wong G.L., Whatling C., et al. Association of genetic variations with NAFLD in lean individuals. Liver Int. 2022;42:149–160. - PubMed
1. Kumar A, Arora A, Sharma P, Jan S, Ara I. Visceral fat and diabetes: associations with liver fibrosis in metabolic dysfunction-associated steatotic liver disease. J Clin Exp Hepatol 2025;15:102378. - PMC - PubMed
1. De A, Bhagat N, Mehta M, Singh P, Rathi S, Verma N, et al. Central obesity is an independent determinant of advanced fibrosis in lean patients with nonalcoholic fatty liver disease. J Clin Exp Hepatol 2025;15:102400. - PMC - PubMed
1. Yamamoto A., Kikuchi Y., Kusakabe T., et al. Imaging spectrum of abnormal subcutaneous and visceral fat distribution. Insights Imaging. 2020;11:24. - PMC - PubMed